GLP1R and hyperinsulinemic hypoglycemia, familial, 4: The treatments include hormone replacement therapy with recombinant leptin for subjects with LEP deficiency, the MC4R agonist setmelanotide for LEPR deficiency,42 and glucagon-like peptide-1 receptor agonists for subjects with MC4R deficiency.43